Actemra 200mg, a drug known scientifically as tocilizumab, is a a potent therapeutical agent primarily utilized for the control of rheumatoid arthritis. This effective substance functions by interfering with the activity of interleukin-6 (IL-6), a regulatory protein crucial in the inflammatory process. Additionally, Actemra exhibits promise in the